Valion Bio (VBIO) Return on Sales [ROS] (2021 - 2025)
Valion Bio (VBIO) posted Return on Sales [ROS] of -1700.68% for Q3 2025, down 564.97 percentage points from -1135.71% a year earlier but up 250.48 percentage points from the prior quarter.
Powered by 
Analysis
Valion Bio (VBIO) Return on Sales [ROS] (2021 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Return on Sales [ROS] at Valion Bio was -1237.55%, down 566.50 percentage points year-over-year; for FY2024, it was -573.85%, up 127.26 percentage points from FY2023.
- Annual Return on Sales [ROS] shows a three-year change of -125.72 percentage points (FY2021 to FY2024).
- In prior years, Valion Bio's Return on Sales [ROS] was -701.11% in FY2023 (-152.30 pp), -548.80% in FY2022 (-100.67 pp) and -448.13% in FY2021.
- Quarterly Return on Sales [ROS] has run from a low of -2151.43% in Q1 2025 to a high of -165.56% in Q4 2024 over five years.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last three quarters, with an average year-over-year change of -363.64 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2024, with a gain of 463.02 percentage points; the weakest was Q1 2025, with a drop of 1708.02 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -1951.16% (Q2 2025), -2151.43% (Q1 2025) and -165.56% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Valion Bio | 378,559.99 | -19.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,700.68% |
| Jun 30, 2025 | -1,951.16% |
| Mar 31, 2025 | -2,151.43% |
| Dec 31, 2024 | -165.56% |
| Sep 30, 2024 | -1,135.71% |
| Jun 30, 2024 | -904.29% |
| Mar 31, 2024 | -443.41% |
| Dec 31, 2023 | -628.57% |
| Sep 30, 2023 | -624.11% |
| Jun 30, 2023 | -1,319.88% |
| Mar 31, 2023 | -562.77% |
| Dec 31, 2022 | -552.94% |
| Sep 30, 2022 | -541.72% |
| Jun 30, 2022 | -571.59% |
| Mar 31, 2022 | -523.60% |
| Dec 31, 2021 | -589.20% |
| Sep 30, 2021 | -443.68% |
| Jun 30, 2021 | -393.66% |
| Mar 31, 2021 | -327.24% |
API Access
Valion Bio Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();